Gastroenterology
Volume 128, Issue 4 , Pages 891-906, April 2005

Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria

  • Sandra C. Kim

      Affiliations

    • Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina
  • ,
  • Susan L. Tonkonogy

      Affiliations

    • North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina
  • ,
  • Carol A. Albright

      Affiliations

    • Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina
  • ,
  • Julia Tsang

      Affiliations

    • Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina
  • ,
  • Edward J. Balish

      Affiliations

    • University of Wisconsin, Madison, Wisconsin
    • Medical University of South Carolina, Charleston, South Carolina
  • ,
  • Jonathon Braun

      Affiliations

    • Department of Pathology, University of California, Los Angeles, California
  • ,
  • Mark M. Huycke

      Affiliations

    • Department of Veterans Affairs Medical Center and University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • ,
  • R. Balfour Sartor

      Affiliations

    • Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina
    • Corresponding Author InformationAddress requests for reprints to: R. Balfour Sartor, MD, Center for Gastrointestinal Biology and Disease, CB #7032, Room 7309A, Biomolecular Research Building, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7032; fax: (919) 843-6899.

Received 4 March 2004; accepted 15 December 2004.

Background & Aims: To explore the hypothesis that selective immune responses to distinct components of the intestinal microflora induce intestinal inflammation, we characterized disease kinetics and bacterial antigen–specific T-cell responses in ex germ-free interleukin 10−/− and wild-type control mice monoassociated with Enterococcus faecalis, Escherichia coli, or Pseudomonas fluorescens. Methods: Colitis was measured by using blinded histological scores and spontaneous interleukin 12 secretion from colonic strip culture supernatants. Interferon γ secretion was measured from mesenteric or caudal lymph node CD4+ T cells stimulated with bacterial lysate–pulsed antigen-presenting cells. Luminal bacterial concentrations were measured by culture and quantitative polymerase chain reaction. Results: Escherichia coli induced mild cecal inflammation after 3 weeks of monoassociation in interleukin 10−/− mice. In contrast, Enterococcus faecalis–monoassociated interleukin 10−/− mice developed distal colitis at 10–12 weeks that was progressively more severe and associated with duodenal inflammation and obstruction by 30 weeks. Neither bacterial strain induced inflammation in wild-type mice, and germ-free and Pseudomonas fluorescens–monoassociated interleukin 10−/− mice remained disease free. CD4+ T cells from Enterococcus faecalis– or Escherichia coli–monoassociated interleukin 10−/− mice selectively produced higher levels of interferon γ and interleukin 4 when stimulated with antigen-presenting cells pulsed with the bacterial species that induced disease; these immune responses preceded the onset of histological inflammation in Enterococcus faecalis–monoassociated mice. Luminal bacterial concentrations did not explain regional differences in inflammation. Conclusions: Different commensal bacterial species selectively initiate immune-mediated intestinal inflammation with distinctly different kinetics and anatomic distribution in the same host.

Abbreviations used in this paper:  APC, antigen-presenting cell , CLN, caudal lymph node , GF, germ-free , IFN, interferon , IL, interleukin , IL-10−/−, interleukin 10 deficient , KLH, keyhole limpet hemocyanin , MLN, mesenteric lymph node , PCR, polymerase chain reaction , SPF, specific pathogen free , TG, transgenic , WT, wild type.

 

 Supported by NIH Grant R01 DK53347 (to R.B.S. and S.L.T.), NIH Grant T32 DK07634 (to S.C.K.), the Center for Gastrointestinal Biology and Disease (NIH Grant P30 DK34987) pilot feasibility grant (to S.C.K.), and Core Laboratories, Crohn’s and Colitis Foundation of America research grants (to R.B.S. and E.J.B.) and research fellowship award (to S.C.K.).

PII: S0016-5085(05)00178-2

doi:10.1053/j.gastro.2005.02.009

Gastroenterology
Volume 128, Issue 4 , Pages 891-906, April 2005